2'-Deoxyuridine

未知生产厂商

2'-Deoxyuridine. An antimetabolite that is converted to deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemias due to vitamin B12 and folate deficiencies. [PubChem]

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

技术标识符

化学式: C₉H₁₂N₂O₅
CAS 编号: 951-78-0
UNII ID: W78I7AY22C

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
EP 3393453 A1申请人: NUCANA PLC优先权: 2015
CN
EP
US
WO
12 件公开
Methods and compositions involving immunostimulatory oligodeoxynucleotides
US 8568742 B2申请人: SCHMIDT WALTER优先权: 2000
CN
EP
US
WO
10 件公开
Phosphoramidate derivatives of 5-fluoro-2-deoxyuridine for use in the treatment of cancer
US 8933053 B2申请人: MCGUIGAN CHRISTOPHER优先权: 2011
US
8 件公开
METHODS FOR INCREASING BLOOD PLASMA 2'-DEOXYURIDINE (DURD) AND THYMIDYLATE SYNTHASE INHIBITION
EP 3848036 A3申请人: ISOFOL MEDICAL AB优先权: 2017
CN
EP
US
5 件公开
Process for preparation of (E)-5-(2-bromovinyl) -2'-deoxyuridine
CN 1494550 A申请人: MENARINI RICERCHE SPA优先权: 2001
CN
US
3 件公开
TREATMENT REGIMENS
US 20240293439 A1申请人: NUCANA PLC优先权: 2017
CN
US
2 件公开
METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM COMPRISING 5-ETHYNYL-2'-DEOXYURIDINE
US 20260034158 A1申请人: UNIV NORTH CAROLINA CHAPEL HILL优先权: 2022
US
WO
2 件公开
SYNTHESIS OF NUCLEOSIDE DERIVATIVES
US 20250296948 A1申请人: NUCANA PLC优先权: 2022
CN
US
2 件公开
Immunostimulatory oligodeoxynucleic molecules
US 7858588 B2申请人: INTERCELL AG优先权: 2001
US
2 件公开
Decoy compositions for treating and preventing brain diseases and disorders
US 2006135449 A1申请人: SAWA YOSHIKI优先权: 2002
US
2 件公开

药物